RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 67-77
  • Pacific Pact Could Hurt Drug Innovation, Drug Makers

    Pacific Pact Could Hurt Drug Innovation, Drug Makers
    This month, negotiations over the Trans-Pacific Partnership resume in Australia. Officials from the United States and 11 other major economies are meeting to settle the final details of the trade pact, with the hope of passing the final deal by year's...
  • Salix Pharmaceuticals drops tax inversion deal amid backlash

    Salix Pharmaceuticals drops tax inversion deal amid backlash
    Salix Pharmaceuticals called off its merger with a foreign drug maker Friday, citing the political backlash against tax inversion deals. The deals—in which a company reincorporates abroad to gain lower taxes—drew fire this summer after...
  • Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana

    Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana
    Nazareth police said an undercover drug buy Wednesday netted more than 50 bags of heroin, prescription painkillers and synthetic marijuana. Pedro Alexander Vera, 25, of the 1200 block of Livingston Street, Bethlehem, is charged with manufacturing...
  • Obamacare Sunshine Act sheds light on $3.5B paid to doctors

     Obamacare Sunshine Act sheds light on $3.5B paid to doctors
    U.S. doctors and teaching hospitals received nearly $3.5 billion from pharmaceutical companies and medical device manufacturers over the last five months of 2013, according to a partial set of data released Tuesday by the federal government. The data...
  • Hospira gets warning from FDA over drug manufacturing violations

    Hospira gets warning from FDA over drug manufacturing violations
    Hospira said Wednesday it received a warning letter from the Food and Drug Administration after an inspection of its Australian manufacturing facility this year identified "significant violations" of drug manufacturing practices. The warning was...
  • Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...
  • AbbVie partners with Google to develop new drugs for aging

    AbbVie partners with Google to develop new drugs for aging
    A startup backed by Google, the Silicon Valley powerhouse whose innovations range from its eponymous search engine to self-driving cars, is teaming up with a North Chicago drug company to develop treatments for diseases tied to aging. Drugmaker AbbVie...
  • Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September

    Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September
    For months, Advanced Grow Labs LLC — one of Connecticut's four medical marijuana growing companies — slogged through the process of competing for a state license, securing local zoning approvals, and outfitting a building to state...
  • New Haven's Marinus Pharmaceuticals Goes Public

    Marinus Pharmaceuticals, an eight-person company working on a drug that may be effective against epileptic seizures, went public Thursday with a stock price of $8 a share. The shares traded as high as $8.16 on Thursday on the NASDAQ exchange, and...
  • Baxter has no plans for inversion with spinoff

     Baxter has no plans for inversion with spinoff
    While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon. The Deerfield-based health...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...